COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2023 |
Jan. 02, 2024 |
Dec. 31, 2022 |
|
| Subsidiary, Sale of Stock [Line Items] | |||
| Fee payable on aggregate gross proceeds (as percentage) | 4.50% | ||
| Aggregated gross proceeds amount of advisory fee payable | $ 5,175,000 | ||
| Common stock, shares issued | 3,336,500 | 3,336,500 | |
| Subsequent Event [Member] | |||
| Subsidiary, Sale of Stock [Line Items] | |||
| Common stock, shares issued | 575,000 | ||
| IPO [Member] | |||
| Subsidiary, Sale of Stock [Line Items] | |||
| Underwriting discount (in percentage) | 1.00% | ||
| Underwriting discount | $ 1,150,000 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|